Parkinson's disease: From bench to bedside - 14/09/20

Doi : 10.1016/j.neurol.2019.11.002

A. Draoui ^a, O. El Hiba ^a,⁎, ^b , A. Aimrane ^a, A. El Khiat ^a, H. Gamrani ^a,⁎
^a Neuroscience, Pharmacology and Environment Unit, Faculty of Sciences Semlalia, Cadi Ayyad University, Avenue My Abdellah, B.P. 2390, Marrakesh, Morocco
^b Laboratory of Biotechnologies, Biochemistry and Nutrition, Faculty of Sciences, Chouaib Doukkali University El Jadida, Route Ben Maachou, B.P. 20, Avenue des Facultés, El Jadida, Morocco

^⁎Corresponding authors.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

pages	17
Iconographies	11
Vidéos	0
Autres	0

Abstract

Parkinson's disease is a very complex public health problem with different etiologies and a wide range of clinical features including motor and non-motor symptoms. The aim of the current report is to review the latest advances in the understanding of PD etiologies, diagnosis, epidemiology and an overview of the earlier and latest advances in the management of PD, from L-DOPA to adult astroglia reprogramming into dopaminergic neurons in vivo.

Le texte complet de cet article est disponible en PDF.

Keywords : Parkinson's disease, Symptomatology, Epidemiology, Pathophysiology, Etiology, Neuroinflammation, Risk factors, Treatments